Status:
COMPLETED
AuraOnce Performance Observation
Lead Sponsor:
Ambu A/S
Conditions:
Anesthesia
Eligibility:
All Genders
18+ years
Brief Summary
This study is designed as a single-center, prospective observational, non-controlled, non-interventional study with an investigation period lasting for one day (during one bronchoscopy procedure). The...
Detailed Description
This study is designed as a single-center, prospective observational, non-controlled, non-interventional study with an investigation period lasting for one day (during one bronchoscopy procedure). The...
Eligibility Criteria
Inclusion
- Subjects \> 18 years
- Subjects planned for diagnostic flexible bronchoscopy procedure in general anesthesia using a laryngeal mask.
Exclusion
- \- Subjects where use of AuraOnce cannot be clinically justified
Key Trial Info
Start Date :
October 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 5 2019
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04128527
Start Date
October 9 2019
End Date
November 5 2019
Last Update
November 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100